RANI
Rani Therapeutics Holdings, Inc.$0.68+0.03 (+4.22%)Prev Close$0.65·MCap$58.1M·P/E—·Vol764.8K·Yield—
▲
Buys (12M)
1
$1.26M
▼
Sells (12M)
0
$0.00
◆
Net Activity
Net Buyer
$1.26M
●
Active Insiders
1
last 12 mo
Over the past 12 months, insider activity at Rani Therapeutics Holdings, Inc. (RANI) has been exclusively buying, with 1 insider purchase totaling $1.26M and 0 insider sales totaling $0.00. The most recent insider transaction was by IMRAN MIR A (Director), who purchased $1.26M worth of shares on Oct 23, 2025. Rani Therapeutics Holdings, Inc. operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $58.1M.
RANI Insider Trading Activity
Showing 1–50 of 56
1 / 2
RANI Insider Buying Activity
The following table shows recent insider purchases of Rani Therapeutics Holdings, Inc. (RANI) stock reported via SEC Form 4 filings.
RANI Insider Selling Activity
The following table shows recent insider sales of Rani Therapeutics Holdings, Inc. (RANI) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Oct 17, 2024 | South Cone Investments Limited Partnership | 10% Owner | Sell | 3,829,360 | $2.65 | $10.14M5.9% OS | 8,825,932-30% |
| Dec 8, 2023 | Quiroga Cortes Isidoro Alfonso | 10% Owner | Sell | 5,265,165 | $2.01 | $10.58M8.1% OS | 8,400-100% |
RANI Insiders
South Cone Investments Limited Partnership
10% Owner
Bought $12.78MSold $10.14M
40 tradesLast: Oct 17, 2024
Similar Stocks to RANI
VRTX
Vertex Pharmaceuticals Incorporated
$476.29+0.08%
$126.50B
REGN
Regeneron Pharmaceuticals, Inc.
$662.73+1.01%
$68.29B
ALNY
Alnylam Pharmaceuticals, Inc.
$275.93-1.72%
$43.19B
RVMD
Revolution Medicines, Inc.
$185.71+0.42%
$40.34B
MRNA
Moderna, Inc.
$68.11+1.00%
$27.09B
INSM
Insmed Incorporated
$109.25-0.67%
$25.06B
INCY
Incyte Corporation
$114.43-0.30%
$23.32B
UTHR
United Therapeutics Corporation
$530.63+0.75%
$23.22B